ELV · 10-Q · 2026Q2 · Full report
Pricing Trends
Elevance Health, Inc. · 2026-07-15 · Importance 19 · Surprise 6 · No source text
Elevance states it prices health benefit products to reflect anticipated medical cost trends but faces timing lags and competitive pressures that can leave pricing misaligned with current underlying costs. The company warns Medicare and Medicaid funding changes and delays in governmental approvals can materially affect revenue recognition and cash flows (premium increases must be deferred until final approval). Product pricing remains competitive in the market, and pricing adjustments are made in response to legislation, regulation and competitor actions. Management flags the potential for significant deferral effects when government rate approvals are delayed.
Key facts
- Health Benefits operating revenue for the three months ended June 30, 2026 was $42,720 compared to $41,582 for the three months ended June 30, 2025, an increase of $1,138 (2.7%). source
- Operating revenue within our Commercial line of business related to our Individual ACA plans was $2,720 for the three months ended June 30, 2026 and $2,328 for the three months ended June 30, 2025. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +2.3% | Health Benefits operating revenue for the three months ended June 30, 2026 was $42,720 compared to $41,582 for the three months ended June… |
| revenue | positive | realized | +0.8% | Operating revenue within our Commercial line of business related to our Individual ACA plans was $2,720 for the three months ended June… |